Current Ratio of Rein Therapeutics, Inc. from 31 Mar 2018 to 30 Sep 2025

Taxonomy & unit
ratio: %
Description
The current ratio is a liquidity ratio that measures a company's ability to cover its short-term obligations with its current assets.
Summary
Rein Therapeutics, Inc. quarterly Current Ratio in % history and change rate from 31 Mar 2018 to 30 Sep 2025.
  • Rein Therapeutics, Inc. Current Ratio for the quarter ending 30 Sep 2025 was 134%, a 64% decline year-over-year.
Current Ratio, Quarterly (%)
Current Ratio, YoY Quarterly Change (%)

Rein Therapeutics, Inc. Quarterly Current Ratio (%)

Period Value YoY Chg Change % Date
Q3 2025 134% -239% -64% 30 Sep 2025
Q2 2025 188% -244% -56% 30 Jun 2025
Q1 2025 286% -206% -42% 31 Mar 2025
Q4 2024 327% -289% -47% 31 Dec 2024
Q3 2024 373% -350% -48% 30 Sep 2024
Q2 2024 433% -234% -35% 30 Jun 2024
Q1 2024 492% -132% -21% 31 Mar 2024
Q4 2023 616% -96% -13% 31 Dec 2023
Q3 2023 723% -88% -11% 30 Sep 2023
Q2 2023 666% -293% -31% 30 Jun 2023
Q1 2023 624% -535% -46% 31 Mar 2023
Q4 2022 711% -672% -49% 31 Dec 2022
Q3 2022 811% -419% -34% 30 Sep 2022
Q2 2022 959% +12% +1.3% 30 Jun 2022
Q1 2022 1159% +484% +72% 31 Mar 2022
Q4 2021 1383% +1060% +327% 31 Dec 2021
Q3 2021 1230% +920% +296% 30 Sep 2021
Q2 2021 947% +607% +178% 30 Jun 2021
Q1 2021 676% +288% +74% 31 Mar 2021
Q4 2020 324% -94% -22% 31 Dec 2020
Q3 2020 311% -126% -29% 30 Sep 2020
Q2 2020 340% -99% -23% 30 Jun 2020
Q1 2020 388% -53% -12% 31 Mar 2020
Q4 2019 417% -146% -26% 31 Dec 2019
Q3 2019 437% -268% -38% 30 Sep 2019
Q2 2019 439% -467% -52% 30 Jun 2019
Q1 2019 441% -381% -46% 31 Mar 2019
Q4 2018 563% 31 Dec 2018
Q3 2018 704% 30 Sep 2018
Q2 2018 907% 30 Jun 2018
Q1 2018 822% 31 Mar 2018
* An asterisk sign (*) next to the value indicates that the value is likely invalid.